ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020 Conference call
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020 Conference call
Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 million Annual operating expenses
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Feb 23, 2021– Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing
2020 Net Revenues of $83.1 Million Increased 19{f13b67734a7459ff15bce07f17c500e58f5449212eae0f7769c5b6fbcf4cc0c4} over 2019 Fourth Quarter Net Revenues of
NEW HAVEN, Conn., March 1, 2021 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven” or the
LEXINGTON, Mass.–(BUSINESS WIRE)–Feb 25, 2021– Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Feb 23, 2021– Intuit Inc. (Nasdaq: INTU), maker of TurboTax, QuickBooks, Credit
© Provided by Daily Mail MailOnline logo New York City Mayor Bill de Blasio has
The Chase Company Full Banking℠ account is a adaptable and economical selection for compact small
Fourth quarter 2020 net income available to common stockholders of $532 million ($1.47 per diluted